Clinical Wins and Daily Practice Introduction A single cardiovascular imaging platform like Circle’s cvi 42 changes daily work for cardiologists and radiologists from “tool juggling” to focused clinical practice. But it also asks for effort and carries real, though manageable, risks. Seeing this change from your perspective, the people interpreting images and shaping programs, makes it easier to decide whether adopting a unified platform is worthwhile. What clinicians gain from one platform Less friction, more clinical time With one platform across MR, CT, structural heart, and EP: You spend less time deciding which tool to open and more time deciding what the data means. One login, one interface, and one workflow logic govern all modalities. Measurements, annotations, and reports behave consistently, so you aren’t constantly switching “UI languages.” AI and automation (e.g., contours, plaque, TAVR workflows) are applied the same way regardless of scanner or modality. This creates cognitive ease, a predictable environment where your brain can focus on nuance and complex decisionmaking instead of navigation. Better consistency and confidence A single platform builds one mental model for cardiac data: acquisition, processing, quantification, and reporting. Standardized protocols and templates reduce variability between readers and sites. Quantification tools remain the same across cases, deepening expertise in one toolkit. Shared measurement formats simplify heartteam discussions and QA reviews. This strengthens diagnostic confidence and supports defensible, consistent decisions. Stronger positioning for advanced and reimbursed work With MR, CT, structural heart, and electrophysiology workflows unified: Advanced workflows (perfusion, strain, plaque) feel like natural extensions of current practice. New reimbursed features (like AIbased plaque quantification) integrate smoothly into routine CCTA reads. Research and innovation benefit from standardized, unified data exports. This positions programs to stay clinically advanced and financially competitive. Less burnout, more sustainable practice Fragmented tools mean more clicks, context shifts, and afterhours work. Integrating platforms can: Reduce duplicate actions via shared worklists and structured reporting. Lower cognitive load through interface consistency. Simplify coverage and crosstraining, so expertise isn’t isolated to one person. Behavioral science shows that reducing friction and restoring control is as important as cutting workload—key factors for preventing burnout. Stay tuned for Part 4: The Effort, Risks, and Why It’s Worth It. While the clinical and operational gains are clear, shifting to a single platform isn't "zero effort". In our final installment, we’ll have a candid discussion about the implementation valley—addressing common concerns like short-term slowdowns and vendor dependence—and show how these risks are mitigated to create a safer, fairer, and more transparent environment for everyone.
For years, the Coronary Artery Calcium (CAC) score has been the gold standard for a quick, non-invasive look at heart disease risk. It’s a vital tool that has helped millions of patients understand if they have "hardening of the arteries." But while a calcium score tells us that plaque is present, it only tells part of the story. As medical technology evolves, we are moving beyond simply identifying the presence of calcium to a much more detailed understanding of heart disease. With the advent of AI-enabled coronary plaque analysis, such as cvi42 | Plaque , patients and physicians now have access to a deeper level of insight that was previously impossible to achieve through standard screening alone. What is AI-Enabled Coronary Plaque Analysis? While a traditional calcium score measures the amount of mineralized (hard) plaque in your coronary arteries, AI-enabled plaque analysis looks at the "soft" or non-calcified plaque as well.
The Clinical Challenge & the cvi42 Solution Executive Summary Cardiovascular disease remains the leading cause of global mortality, yet diagnostic workflows remain fragmented. Traditionally, clinicians have been forced to navigate disconnected systems to assess a patient’s heart: one for anatomy (CCTA), another for function (CMR/Strain), and a third for vascular inflammation (PCAT/Plaque). This "siloed" approach creates diagnostic friction, increases costs, and delays life-saving interventions.
The activation of Category I CPT code 75577 on January 1, 2026, has transformed the reimbursement landscape for AI-enabled coronary plaque analysis, such as Circle Cardiovascular Imaging's FDA-cleared cvi 42 . This FAQ addresses key questions on payers, coverage, coding, payments, opportunities, threats, and value-based care impacts to guide adoption in cardiovascular imaging practices that ultimately lead to commercial viability. For Circle Cardiovascular Imaging customers deploying cvi 42 for plaque analysis, the new CPT 75577 landscape means reliable revenue streams (~$900-1,000 per case) with expanded payer access, but it requires refined billing to navigate bundling and denials. Overall, it accelerates the ROI on cvi 42 by enabling onsite AI processing that captures professional and technical fees hospitals previously outsourced.
